Case Study

Digital Business In Action

Published July 20, 2022

Digital Business In Action

The business culture of an organization is a direct indicator of its ability to deliver on performance goals. By mapping and measuring the internalization of specific cultural dimensions to revenue, an organization can identify gaps in the workforce and bridge them with clinical precision. This enables the organization to harness human energies and direct them toward catalyzing unified goals. What is the role of digital technologies, such as data and analytics, in understanding and mapping organizational culture to performance?

Download Case Study

Data Analytics Digital Business

Digital Business Methodology

The Growth Code

We give you the DBM Growth Code: A step-by-step guide written by practitioners to help you accelerate digital business.

Latest Insights

Blog

Revolutionizing Retail: Empowering Excellence through AI-Powered Transformation

Analytics Platform Modernization

Blog

Master AWS Security: Threat Detection with Amazon GuardDuty

Cloud Infosec

Case Study

Enhancing Retail Planning: Streamlining Transfer Engine Efficiency

Digital Business Platform Modernization

Case Study

Empowering Retail Excellence with AI-Powered Transformation

Analytics Platform Modernization

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.	Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.	Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.	Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.	Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.	Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.	Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.	Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.	Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.	Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.	Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.	Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indications	Utilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes